C-J Advisory’s Gilead Sciences GILD Stock Holding History

C-J Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-121	Closed	-$8K	–	84
2019 Q3	$8K	Hold	121	–	–	0.01%	133
2019 Q2	$8K	Hold	121	–	–	0.01%	133
2019 Q1	$8K	Hold	121	–	–	0.01%	148
2018 Q4	$8K	Hold	121	–	–	0.01%	116
2018 Q3	$9K	Hold	121	–	–	0.01%	122
2018 Q2	$9K	Buy	+121	New	+$8.54K	0.01%	115
2017 Q1	–	Sell	-171	Closed	-$12K	–	128
2016 Q4	$12K	Hold	171	–	–	0.01%	101
2016 Q3	$14K	Buy	+171	New	+$13.9K	0.01%	97

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

C-J Advisory's GILD Position: Q4 2019 in Review

C-J Advisory sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 121 shares — an estimated $8K sold.

C-J Advisory first reported a position in GILD in Q3 2016 and held it in 8 quarters. The position peaked at $14K in Q3 2016. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

C-J Advisory reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
C-J Advisory sold 121 Gilead Sciences shares in Q4 2019, an estimated $8K.
C-J Advisory first reported a position in Gilead Sciences in Q3 2016 and held it in 8 quarters.
C-J Advisory's Gilead Sciences position peaked at $14K in Q3 2016.
1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on C-J Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.